The European Society of Gynaecological Oncology (ESGO), the International Society of
Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour …

Introduction Many national guidelines concerning the management of ovarian cancer
currently advocate the risk of malignancy index (RMI) to characterise ovarian pathology …

The Ovarian-Adnexal Reporting and Data System (O-RADS) US risk stratification and
management system is designed to provide consistent interpretations, to decrease or …

Objectives To prospectively assess the diagnostic performance of simple ultrasound rules to
predict benignity/malignancy in an adnexal mass and to test the performance of the risk of …

Background Subjective evaluation of gray-scale and Doppler ultrasound findings (ie, pattern
recognition) by an experienced examiner and preoperative serum levels of CA-125 can both …

Background: Correct characterisation of ovarian tumours is critical to optimise patient care.
The purpose of this study is to evaluate the diagnostic performance of the International …

Characterizing ovarian masses enables patients with malignancy to be appropriately triaged
for treatment by subspecialist gynecological oncologists, which has been shown to optimize …

PURPOSE: The combination of two tumour markers, CA125 and HE4, in the risk of ovarian
malignancy assay (ROMA) has been shown to be successful in classifying patients into …

Objective To assess the clinical usefulness of a structured reporting system based on
ultrasound findings for management of adnexal masses. Methods This was a prospective …

Objective To determine the diagnostic performance of International Ovarian Tumor Analysis
(IOTA)'simple'rules for discriminating between benign and malignant adnexal masses …